hero-purple

About

With founders who are global leaders in the structural biology of 14-3-3 proteins and their role in a wide range of protein-protein interactions, our team is developing a new class of medicines that can modulate previously undruggable targets and influence currently accessible ones in new ways. These small molecule stabilizers of 14-3-3:client complexes have the potential to address serious unmet needs in important therapeutic areas including cancer, metabolic disorders, neurodegenerative and infectious diseases.

Our company is committed to aggressively expanding the boundaries of medicine through treatments that modulate some of the most challenging and potentially impactful targets identified across the proteome, with the goal of treating diseases that currently lack a cure and helping patients live longer and healthier lives.

Ambagon-Photo-SClarke1162Edit-Web-sized

Scott Clarke

Chief Executive Officer

Ambagon-Photo-COttmann1324Edit-Web-sized

Christian Ottmann, Ph.D.

Co-Founder & Chief Technology Officer

Ambagon-Photo-NPryor1759Edit-Web-sized

Nancy Pryer, Ph.D.

Chief Scientific Officer

Ambagon-Photo-SRichards1537Edit-Web-resized

Steven Richards, Ph.D.

Vice President, Chemistry

Ambagon-Headshots-TanjaMeyer

Tanja Meyer, Ph.D.

VP & Head of Corporate Strategy & Business Development

Ambagon-Headshots-ThomasMarty

Thomas Marty

Vice President, Finance

Michelle Arkin, Ph.D.

Co-Founder, Amgabon Therapeutics

Roel Bulthuis

Managing Partner, Inkef Capital

Margarita Chavez

Managing Partner, AbbVie Ventures

Scott Clarke

Chief Executive Officer, Ambagon Therapeutics

Peter Dudek, Ph.D.

President & Managing Partner, MRL Ventures Fund

Melissa McCracken, Ph.D.

Partner, Nextech Invest

Janwillem Naesens

Managing Partner, DROIA Ventures

Adam Rosenberg

Chair, Venture Partner, RA Capital

Michelle Arkin, Ph.D.

University of California, San Francisco

Alan Ashworth, Ph.D., FRS

University of California, San Francisco

Carolyn Bertozzi, Ph.D.

Stanford University

Gideon Bollag, Ph.D.

Opna Immuno-Oncology

Luc Brunsveld, Ph.D.

Co-Founder, Scientific Advisor

Steve Davidsen, Ph.D.

AbbVie

Geraldine Harriman, Ph.D.

HotSpot Therapeutics

Ali Tavassoli, Ph.D.

University of Southampton

0022_Ambagon-Photo-MArkinEdit

Michelle Arkin, Ph.D.

Co-founder

0021_Ambagon-Photo-ZZhang4898Edit

Zhen Zhang, Ph.D.

Senior Director, Cancer Biology

0000_Ambagon-Photo-GMiley1509Edit

Galen Miley, Ph.D.

Scientist, Chemistry

0005_Ambagon-Photo-LStevers1248Edit

Loes Stevers, Ph.D.

Senior Scientist, Biochemistry

0003_Ambagon-Photo-LDemmers1406Edit

Laura Demmers, Ph.D.

Scientist, Proteomics

0002_Ambagon-Photo-ESijbesma1294Edit

Eline Sijbesma, Ph.D.

Scientist, Biochemistry

Ambagon-Headshots-MichelleHowarth

Michelle Howarth, Ph.D.

Senior Scientist, Cell Biology

0015_Ambagon-Photo-WGoodheart4925Edit-copy

William Goodheart

Associate Scientist, Cancer Biology

0011_Ambagon-Photo-LBrunsveld1806Edit

Luc Brunsveld, Ph.D.

Co-founder

0013_Ambagon-Photo-RdeVries1648Edit

Rens de Vries, Ph.D.

Senior Scientist, Structural Biology

Ambagon-Headshots-DharaAmin

Dhara Amin, Ph.D.

Associate Director, Cell Biology

Ambagon-Headshots-AaronAlbers

Aaron Albers, Ph.D.

Associate Director, Chemistry

Ambagon-Headshots-DanielleAubele

Danielle Aubele, Ph.D.

Senior Director, Chemistry

Ambagon-Headshots-SamuelChang

Samuel Chung, Ph.D.

Senior Scientist, Cell Biology

Ambagon-Headshots-NancyDeng

Nancy Deng, Ph.D.

Senior Director, Computational Chemistry

Ambagon-Headshots-PaulHollenbach

Paul Hollenbach

Scientist, Cell Biology

Ambagon-Headshots-TaggraNicolleJackson

Taggra-Nicole Jackson

Senior Research Associate, Cell Biology

Ambagon-Headshots-KarolinaKaminska

Karolina Kaminska

Senior Research Associate, Cell Biology

Ambagon-Headshots-MeredithKuo

Meredith Kuo, Ph.D.

Senior Scientist, Cell Biology

Ambagon-Headshots-ValentinaKwak

Valentina Kwak, Ph.D.

Senior Scientist, Chemistry

Ambagon-Headshots-PhuonglyPham

Phuongly Pham

Senior Scientist, Chemistry

Ambagon-Headshots-JiaXie

Jia Xie, Ph.D.

Senior Scientist, Cell Biology

Ambagon-Headshots-YingZhang

Ying Zhang, Ph.D.

Executive Director, Early Development & Platform

MaartenAltelaar

Maarten Altelaar, Ph.D.

Executive Director, Proteomics and Biochemistry

MrudulaSrikanth

Mrudula Srikanth

Senior Research Associate, Biochemistry

TomvandeWijngaart

Tom van de Wijngaart

Research Associate

EsraBozkurt

Esra Bozkurt, Ph.D.

Scientist, Structural Biology

LauraButhker

Laura Büthker

Research Associate, Biochemistry

WillemVanDenHout

Willem van den Hout

Research Associate, Chemistry

BasDeJong

Bas de Jong

Intern, Proteomics

CeriZwart

Ceri Zwart

Senior Research Associate, Proteomics

Investors

RAcapital logo
mrl ventures fund logo
mission bay capital logo
inkef capital logo
droia ventures logo
abbvie logo